GOLDMAN SACHS GROUP INC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 61 filers reported holding IRADIMED CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$2,488,092
+11.0%
56,076
+19.4%
0.00%
Q2 2023$2,242,205
+17.2%
46,967
-3.4%
0.00%
Q1 2023$1,912,606
+22.4%
48,605
-12.0%
0.00%
Q4 2022$1,563,023
+12.9%
55,250
+19.9%
0.00%
Q3 2022$1,385,000
+9.1%
46,066
+23.1%
0.00%
Q2 2022$1,270,000
-18.0%
37,423
+8.5%
0.00%
Q1 2022$1,548,000
+134.9%
34,505
+142.3%
0.00%
Q4 2021$659,000
+35.6%
14,240
-1.6%
0.00%
Q3 2021$486,000
+131.4%
14,471
+102.5%
0.00%
Q2 2021$210,000
-19.8%
7,145
-23.5%
0.00%
Q1 2019$262,000
-13.2%
9,344
-24.4%
0.00%
Q4 2018$302,000
-18.2%
12,363
+24.5%
0.00%
Q3 2018$369,000
+49.4%
9,930
-16.6%
0.00%
Q2 2018$247,000
-14.8%
11,901
-63.5%
0.00%
Q1 2017$290,000
+28.3%
32,619
+252.1%
0.00%
Q3 2015$226,000
-22.9%
9,263
-26.4%
0.00%
Q2 2015$293,000
+24.7%
12,585
-18.3%
0.00%
Q1 2015$235,000
+18.1%
15,404
+0.0%
0.00%
Q4 2014$199,000
+41.1%
15,403
-23.4%
0.00%
Q3 2014$141,00020,1060.00%
Other shareholders
IRADIMED CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders